A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial
Crossref DOI link: https://doi.org/10.1371/journal.pone.0226007
Published Online: 2019-12-10
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Maheu, Emmanuel https://orcid.org/0000-0001-6615-3630
Avouac, Bernard
Dreiser, Renée Liliane
Bardin, Thomas
Funding for this research was provided by:
TRB Chemedica SAS, France
Version of Record valid from 2019-12-10
